Prelude Therapeutics, Inc. (PRLD)
4.33
-0.17
(-3.78%)
USD |
NASDAQ |
May 21, 16:00
4.63
+0.30
(+6.93%)
After-Hours: 19:41
Prelude Therapeutics Shareholders Equity (Quarterly) : 60.18M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 337.40M |
| Sana Biotechnology, Inc. | 119.24M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Agenus, Inc. | -221.22M |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 119.64M |
| Total Liabilities (Quarterly) | 59.46M |
| Debt to Equity Ratio | 0.2945 |
| Current Ratio | 2.028 |
| Net Debt Paydown Yield | 0.03% |